Literature DB >> 4034295

Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk low-birth-weight infants.

L S de Vries, S Lary, L M Dubowitz.   

Abstract

During a 4-year period, 12 premature infants, all less than 34 weeks of gestation and all with a bilirubin level above 240 mumol/L (14 mg/dL) were determined to have bilateral sensorineural deafness. In order to to investigate how far the hyperbilirubinemia or any a associated factor might have been a causative factor, all infants of 34 weeks of gestation or less who had a serum bilirubin level above 240 mumol/L were investigated. For a period of 4 years, 99 infants meeting these criteria were classified as high risk or low risk on the basis of perinatal risk factors. Eight of the 22 high-risk infants with birth weight less than 1,500 g, but only two of 43 high-risk infants with birth weight greater than 1,500 g were deaf (P less than .05). The deaf infants were also matched with infants of normal hearing who had similar bilirubin levels and the same number of adverse perinatal factors. The mean duration of hyperbilirubinemia was significantly longer in the deaf infants (P less than .02), and they appeared to have a greater number of acidotic episodes while they were hyperbilirubinemic. These findings suggest that in healthy preterm infants with birth weight greater than 1,500 g, high bilirubin levels carry little risk, whereas a serum bilirubin level greater than 240 mumol/L in high-risk preterm infants with birth weight of 1,500 g or less is associated with a high risk of deafness.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4034295

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

1.  Auditory brainstem responses (ABR) in neonates with hyperbilirubinemia.

Authors:  A K Gupta; H Raj; N K Anand
Journal:  Indian J Pediatr       Date:  1990 Sep-Oct       Impact factor: 1.967

Review 2.  Use of evoked potentials in preterm neonates.

Authors:  M J Taylor; E Saliba; J Laugier
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

3.  Early prediction of neonatal hyperbilirubinemia.

Authors:  S Awasthi; H Rehman
Journal:  Indian J Pediatr       Date:  1998 Jan-Feb       Impact factor: 1.967

4.  Sensorineural hearing loss and prematurity.

Authors:  E S Marlow; L P Hunt; N Marlow
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

Review 5.  What constitutes a "safe" level of bilirubin concentration in preterm and full term infants?

Authors:  N K Anand; A K Gupta
Journal:  Indian J Pediatr       Date:  1993 Jul-Aug       Impact factor: 1.967

Review 6.  Audiologic impairment associated with bilirubin-induced neurologic damage.

Authors:  Cristen Olds; John S Oghalai
Journal:  Semin Fetal Neonatal Med       Date:  2015-01-07       Impact factor: 3.926

7.  Effect of acidosis on bilirubin-induced toxicity to human erythrocytes.

Authors:  Maria Alexandra Brito; Dora Brites
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

8.  Hyperbilirubinemia and language delay in premature infants.

Authors:  Sanjiv B Amin; Diane Prinzing; Gary Myers
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

9.  Gentamicin Exposure and Sensorineural Hearing Loss in Preterm Infants.

Authors:  Aline Fuchs; Lara Zimmermann; Myriam Bickle Graz; Jacques Cherpillod; Jean-François Tolsa; Thierry Buclin; Eric Giannoni
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

10.  Evaluation of treatment thresholds for unconjugated hyperbilirubinemia in preterm infants: effects on serum bilirubin and on hearing loss?

Authors:  Christian V Hulzebos; Paula van Dommelen; Paul H Verkerk; Peter H Dijk; Henrica L M Van Straaten
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.